Alissa Faris is a counsel in the Precision Medicine and Digital Health Practice Group in Haynes and Boone’s Palo Alto office.
Alissa has extensive experience in worldwide patent counseling for biotechnology clients. She focuses on preparation and prosecution in the areas of therapeutic and diagnostic humanized antibodies with application in the treatment, prevention, and diagnosis of cancer, inflammatory diseases, and neurological diseases, as well as application in the field of regenerative medicine. Alissa also has experience in preparing patentability, freedom-to-operate, non-infringement opinions and re-examinations; intellectual property due diligence reviews; and patent litigation.
Alissa has worked with a wide range of clients, including pharmaceutical companies, biotechnology companies, academic institutions, and start-ups.
- Recognized as a “Rising Star” in Intellectual Property by Super Lawyers, Thomson Reuters, 2016-2017
Selected Client Representations
- Represented a venture capital firm in the intellectual property due diligence on a target biopharmaceutical company, resulting in a $25 million series D investment in the target company.
- Prosecuted or advised on the prosecution of a variety of issued patents.
B.A., Biological Sciences, University of Delaware, 1999
J.D., Seton Hall University School of Law, 2006
Intern to the Honorable Patty Shwartz, U.S. District Court for the District of New Jersey, 2005
U.S. Patent and Trademark Office
Haynes and Boone, LLP has added several patent practitioners to its Precision Medicine and Digital Health Practice Group, further bolstering a practice that San Francisco lawyers Roger Kuan and Jason Novak established a year ago this month. Since March, the group has hired Counsel Alissa Faris, Patent Attorney Michael J. Smith, and Patent Agent Paula Schoeneck, who started May 17. “These stellar [...]